Imaging for staging stage III nonsmall cell lung cancer

J. Vansteenkiste, C. Dooms, H. Becker, P. De Leyn

Source: Breathe 2007; 4: 47-55
Journal Issue: September

PDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Vansteenkiste, C. Dooms, H. Becker, P. De Leyn. Imaging for staging stage III nonsmall cell lung cancer. Breathe 2007; 4: 47-55

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Management of stage I and II nonsmall cell lung cancer
Source: Eur Respir J 2017; 49(1): 1600764; DOI: 10.1183/13993003.00764-2016
Year: 2017




Radiotherapy for stage III non-small cell lung cancer (NSCLC)
Source: European Multidisciplinary Conference in Thoracic Oncology 2009
Year: 2009

Management of locally advanced nonsmall cell lung cancer
Source: Eur Respir Mon; 2009: 44: 260–270
Year: 2009

Interdisciplinary multimodality management of stage III nonsmall cell lung cancer
Source: Eur Respir Rev, 28 (152) 190024; 10.1183/16000617.0024-2019
Year: 2019



Surgical multimodality treatment for stage III non-small cell lung cancer (NSCLC)
Source: Annual Congress 2006 - Integrative approaches for stage III non-small cell lung cancer
Year: 2006


Staging of lung cancer
Source: Eur Respir Mon; 2009: 44: 150–168
Year: 2009

Prognostic factors in patients with resected pathologic stage I and II nonsmall cell lung cancer (NSCLC)
Source: Eur Respir J 2002; 20: Suppl. 38, 269s
Year: 2002

Age and stage at presentation in lung cancer
Source: Annual Congress 2005 - Management of lung cancer: clinical problems
Year: 2005


Comparison of clinic and pathological staging in non-small cell lung cancer
Source: Annual Congress 2010 - Diagnostic and therapeutic problems in surgical oncology
Year: 2010


Prognostic value of Her2/neu in stage IIIA non-small cell lung cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 770s
Year: 2006

Analysis of prognostic factors in patients with stage IIIB, IV non-small cell lung cancer
Source: Annual Congress 2010 - Staging of lung cancer
Year: 2010


Staging and restaging in the era of multimodality treatment
Source: Annual Congress 2006 - Integrative approaches for stage III non-small cell lung cancer
Year: 2006


Survival impact of surgery in the treatment of stage IIIB-IVA non-small cell lung cancer
Source: International Congress 2018 – Lung cancer: personalised medicine
Year: 2018


Use of adjuvants to chemotherapy in stage IV nonsmall cell lung carcinoma (NSCLC)
Source: Eur Respir J 2003; 22: Suppl. 45, 64s
Year: 2003

Radiotherapy with curative intent for stage I and II non-small cell lung cancer
Source: European Multidisciplinary Conference in Thoracic Oncology 2009
Year: 2009

Radio(chemo)therapy in locally advanced nonsmall cell lung cancer
Source: Eur Respir Rev 2015; 25: 65-70
Year: 2016



First- and second-line therapy for advanced nonsmall cell lung cancer
Source: Eur Respir J 2009; 33: 915-930
Year: 2009



Adjuvant chemotherapy in stage IB nonsmall cell lung cancer
Source: Breathe 2009; 5: 361
Year: 2009

International guidelines on stage III N2 nonsmall cell lung cancer: surgery or radiotherapy?
Source: ERJ Open Res, 6 (1) 00159-2019; 10.1183/23120541.00159-2019
Year: 2020